UM School of Medicine Researchers Test Remdesivir as Potential Therapy for COVID-19 Patients
DescriptionNews release announcing the UMB School of Medicine's participation in an NIAID/NIH-sponsored clinical trial of remdesivir as a possible treatment for COVID-19. The research is being conducted through UMSOM’s Center for Vaccine Development and Global Health (CVD) and the Vaccine and Treatment Evaluation Unit (VTEU).
KeywordCoronavirus Disease 2019 (COVID-19)
University of Maryland, Baltimore. Center for Vaccine Development and Global Health (CVD)
University of Maryland, Baltimore. School of Medicine